Maynard Um
-
-
-
-
-
-
-
Telix presents dosimetry data for prostate cancer drug candidate
-
-
-
-
-
-
-
William Blair Shuffles Analyst Conviction List for April 2026
-
-
-
-
-
-
-
CMS grants reimbursement status for Telix's Gozellix prostate imaging agent
-
-
-
-
-
-
-
Telix Pharmaceuticals (TLX) Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
-
-
-
-
-
396,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

